Smart VR Mindfulness for Breast Cancer: Integrating Biofeedback and Evaluating Chemotherapy Effectiveness

Launched by HSIN YI LU · Aug 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help women with breast cancer who are undergoing chemotherapy. Many patients experience stress and various physical and emotional symptoms during treatment, which can make things harder. The trial is looking at whether a special mindfulness program using virtual reality (VR) can help reduce this stress and improve their overall experience. Participants will be divided into three groups: one will use mindfulness-based VR, another will listen to mindfulness-based audio, and the third group will not receive any mindfulness intervention. The researchers aim to see if VR can be more effective than other methods in helping patients feel better during their treatment.

To be eligible for this trial, participants must be adult women aged 18 or older who have been diagnosed with breast cancer and are starting their first round of chemotherapy. They should be able to communicate in Mandarin and be comfortable using a smartphone. It's important that they have not tried mindfulness-based programs before and do not have any severe visual or hearing impairments. If someone joins the trial, they can expect to engage in mindfulness activities that may help improve their mood and reduce stress while receiving care. This study is currently recruiting participants and aims to enhance the understanding of how mindfulness can support women facing breast cancer treatment.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Age above 18 years.
• • Diagnosed with breast cancer stages I to III, with diagnostic codes C50, C79.81, C84.7A, D03.52, D05, D24, D48, or D49; there are no restrictions on tumor type, receptor subtype, or whether breast tumor removal surgery has been performed.
• • Undergoing the first inpatient preoperative or postoperative chemotherapy, without restrictions on the type of medication or treatment cycles.
• • Able to communicate in Mandarin and literate; without cognitive impairments, psychiatric disorders, motion sickness, epilepsy, or a history of drug or alcohol addiction.
• • No prior experience with mindfulness-based interventions. Understanding of the research procedures, agreement to participate, and signing of the informed consent form; owning a smartphone capable of installing the required research applications and able to operate independently.
• Exclusion Criteria:
• • individuals with blindness or visual impairments that preclude the identification of on-screen visuals
• • individuals with auditory impairments preventing the recognition of sounds through headphones.